INFU InfuSystem Holdings, Inc

INFU financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 1337013 Exchange: NYSE SIC: 3841 (Surgical & Medical Instruments & Apparatus)
Showing 3 of 17 annual and 0 of 64 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Accelerated filer<br>Smaller reporting company
Entity Type
Operating
Public Float
$122.27M (Jun 2025)
Industry (SIC)
3841 Surgical & Medical Instruments & Apparatus
Incorporated
DE
Fiscal Year End
December (1231)
Phone
(248) 291-1210
EIN
203341405
Headquarters
ROCHESTER HILLS, MI, 48309
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.
Former Names: HAPC, Inc. (2006–2007) · Healthcare Acquisition Partners Corp. (2005–2006)

▼ Key Metrics (TTM)

As of Jun 30, 2026
Financials
Revenue
$143.34M
Net Income
$8.54M
Total Assets
$97.70M
Total Equity
$59.15M
Total Debt
$20.42M
Free Cash Flow
$22.91M
Ratios
Gross Margin
57.5%
Operating Margin
9.3%
Net Margin
6%
Return on Equity
14.4%
Return on Assets
8.7%
Current Ratio
2.5x
Debt / Equity
0.35x
FCF / Assets
23.4%

▼ FY 2025 Summary Analysis

Annual report ending Dec 31, 2025

Overview and Growth

Fiscal 2025 results for InfuSystem Holdings, Inc combined $143.44M of revenue with net income of $6.63M and an operating cash inflow of $24.41M. At $143.44M, the top line establishes the operating scale supporting the company’s profit and cash-flow profile. Revenue was 6.4% above fiscal 2024 revenue of $134.86M, marking a year-over-year increase. The company reported diluted EPS of $0.31, adding a shareholder-level measure to the absolute income figures considered below. Against diluted EPS of $0.11 in fiscal 2024, the current result was 181.8% higher. The revenue-to-assets relationship was 1.43x, showing the sales generated relative to the resources carried on the balance sheet.

Profitability

The first profit layer was $80.30M of gross profit, the amount available after reported direct revenue costs to absorb operating expenses. The gross-profit relationship equaled 56.0% of revenue, quantifying the portion retained before operating expenses were recognized. Operating income was $11.92M, the earnings remaining from reported operations after the company’s recognized operating cost structure. The operating result equaled 8.3% of revenue, placing the absolute operating-income figure in the context of the company’s sales base. After all reported below-operating-line items, the company recorded net income of $6.63M for the fiscal year. Net margin was 4.6%, meaning that this portion of revenue remained as net income after all recognized expenses. The earnings statement records $10.62M of pretax income, the profit base against which the reported tax provision can be assessed. The pretax margin was 7.4%, relating income before taxes directly to revenue. The reported income-tax provision was $4.00M, the amount recognized between pretax income and the final net-income result. The effective relationship between income tax and positive pretax income was 37.6%, without assuming a statutory-rate comparison.

Liquidity and Capital Structure

At period end, the $100.56M asset base was financed through $43.23M of liabilities and $57.33M of equity. At period end, current assets of $36.34M compared with current liabilities of $20.18M, defining the company’s short-term resource position. At 1.8x, the current ratio shows that short-term assets were greater than short-term liabilities at period end. Reported cash and equivalents were $3.19M, separating immediately recognizable cash resources from the rest of the current-asset base. Cash and equivalents represented 15.8% of current liabilities, showing the portion of near-term obligations matched by reported cash alone. Borrowings totaled $19.62M, adding a fixed financing obligation alongside the company’s equity capital. Debt equaled 0.34x of book equity, describing the relative scale of borrowing and shareholder capital. Debt represented 19.5% of total assets, placing borrowing in the context of the company’s full resource base. The liabilities-to-assets relationship was 43.0%, placing reported obligations against the full positive asset balance. Cash and equivalents equaled 3.2% of total assets, showing the liquid cash component within the company’s broader resource base.

Cash Flow and Earnings Quality

Operating activities produced a cash inflow of $24.41M, giving the cash-flow counterpart to the accrual-based profit measures reported for the year. Operating cash flow equaled 3.68x of net income, showing how strongly accounting earnings converted into cash from operations. Capital spending was $560.00K, absorbing part of the cash generated from operations before free cash flow. Relative to operating cash flow, capital expenditures measured 2.3%, connecting investment intensity with the company’s cash-generation base. After capital spending, free cash flow was $23.85M, leaving cash available for debt reduction, shareholder returns, or further investment. Free cash flow represented 16.6% of revenue, linking post-investment cash generation with the company’s operating scale. Free cash flow equaled 23.7% of total assets, relating post-investment cash generation to the company’s resource base.
Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual (FY)
Quarterly 🔒
Chart 🔒
Annual financial statements for InfuSystem Holdings, Inc
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
Revenue $143.44M $134.86M $125.79M
Cost of Revenue $63.14M $64.46M $62.68M
Gross Profit $80.30M $70.40M $63.11M
OPERATING EXPENSES
SG&A Expense $56.97M $51.21M $45.38M
Operating Income $11.92M $6.89M $4.09M
NON-OPERATING INCOME / EXPENSE
Interest Expense - - $2.17M
Other Income/Expense $2.00K $-55.00K $-67.00K
Pretax Income $10.62M $5.06M $1.85M
Income Tax $4.00M $2.71M $979.00K
Net Income $6.63M $2.35M $872.00K
PER SHARE & SUPPLEMENTAL
Diluted EPS $0.31 $0.11 $0.04
Diluted Shares 21.10M 21.71M 21.65M
EBITDA $25.21M $19.39M $16.60M
Depreciation & Amortization $13.29M $12.50M $12.51M
Balance Sheet
ASSETS
Cash & Equivalents $3.19M $527.00K $231.00K
Accounts Receivable $22.90M $21.16M $19.83M
Inventory $5.39M $6.53M $6.40M
Other Current Assets $4.86M $3.96M $4.16M
Current Assets $36.34M $32.17M $30.62M
PP&E (Net) $3.36M $4.03M $4.32M
Goodwill $3.71M $3.71M $3.71M
Intangible Assets $6.87M $6.46M $7.45M
Other Noncurrent Assets $1.68M $878.00K $1.58M
Noncurrent Assets $64.22M $71.45M $72.30M
Total Assets $100.56M $103.61M $102.92M
LIABILITIES
Accounts Payable $10.82M $9.85M $8.01M
Short-term Debt $0 $0 $0
Other Current Liabilities $9.36M $7.81M $7.70M
Current Liabilities $20.18M $17.66M $15.71M
Long-term Debt $19.63M $23.86M $29.10M
Other Noncurrent Liabilities (derived) $3.43M $4.56M $5.80M
Noncurrent Liabilities $23.05M $28.42M $34.90M
Total Liabilities $43.23M $46.09M $50.61M
EQUITY
Common Stock $2.00K $2.00K $2.00K
Additional Paid-in Capital $117.46M $113.87M $109.84M
Retained Earnings $-60.70M $-57.46M $-58.63M
Accumulated OCI $565.00K $1.12M $1.09M
Total Equity $57.33M $57.53M $52.30M
Total Liabilities & Equity $100.56M $103.61M $102.92M
SUPPLEMENTAL
Total Debt $19.63M $23.86M $29.10M
Shares Outstanding 20.21M 21.27M 21.20M
Check: A − (L + E + NCI) - - -
Cash Flow Statement
Cash from Operations $24.41M $20.46M $11.22M
Capital Expenditures $560.00K $1.09M $1.02M
Cash from Investing $-6.79M $-13.24M $-6.73M
Cash from Financing $-14.96M $-6.92M $-4.42M
Free Cash Flow $23.85M $19.37M $10.20M
Beginning Cash (CFS) $527.00K $231.00K -
Net Change in Cash $2.66M $296.00K -
Effect of FX on Cash - - -
Calculated Ending Cash $3.19M $527.00K -
Cash per BS $3.19M $527.00K $231.00K
Cash scope difference (CFS − BS) - - -
Cash per CFS $3.19M $527.00K $231.00K

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

What is InfuSystem Holdings, Inc's annual revenue?

InfuSystem Holdings, Inc reported $143.34M in revenue for trailing twelve months (ending June 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.

Is InfuSystem Holdings, Inc profitable?

Yes. InfuSystem Holdings, Inc reported $8.54M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.

What is InfuSystem Holdings, Inc's debt level?

InfuSystem Holdings, Inc carries $20.42M in total debt as of trailing twelve months. Total shareholders' equity stands at $59.15M.

Does InfuSystem Holdings, Inc generate free cash flow?

Yes. Free cash flow was $22.91M for trailing twelve months. Operating cash flow was $23.37M.